Immunohistochemical Diversity of Endometrial Carcinoma and Their Implications in Prognosis: A Prospective Clinicopathological Study in a Tertiary Care Hospital of Eastern India.
The Journal of Obstetrics and Gynecology of India · 2025-04 · 75 (S1) · 166-172
DOI: 10.1007/s13224-024-02046-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Obstetrics and Gynecology of India, online erschienen am 31.08.2024. Verfasst von Rajashree Pradhan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Medicine and Sagore Dutta Hospital, Kolkata, West Bengal India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Endometrial cancer is the sixth most common cancer in women worldwide with gradually increasing incidence and mortality rate. The most recent classification of endometrial carcinoma (EC) with diagnostic flowchart includes both immunohistochemical and molecular markers for prognostic purpose and better management of endometrial cancer. In this study, we want to analyze various immunohistochemical (IHC) markers in EC and their prognostic significance.
Methods
This was a prospective study conducted from August 2016 to February 2024. We studied 168 cases of EC for histopathological subtypes, grading and various IHC markers such as Estrogen Receptor (ER), Her 2 Neu, Cytokeratin 5/6, Epithelial Membrane Antigen (EMA) and p53.
Results
In our study, most common histological subtype was endometrioid (132) followed by serous (17), mucinous (8), clear cell (7) and carcinosarcoma (4). ER expression was mostly seen in endometrioid type. Loss of ER expression and Her 2 expression along with p53 over expression was not only associated with high grade EC but also with advanced clinical stage and lymph node metastasis.
Conclusion
Immunohistochemical markers play a definite role in risk stratification and specific individual oriented therapy in endometrial cancer patients. Supplementary Information: The online version contains supplementary material available at 10.1007/s13224-024-02046-9.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, College of Medicine and Sagore Dutta Hospital, Kolkata, West Bengal India.
- Department of Pathology, Medical College Kolkata, Kolkata, West Bengal India.
- Department of Pathology, Rampurhat Government College and Hospital, NH14Rampurhat, Birbhum, West Bengal 731224 India.
- Department of Pathology, College of Medicine and Sagore Dutta Hospital, Kolkata, West Bengal 700058 India.
ORCID-Profile: Rajashree Pradhan, Sajeeb Mondal, Upasana Mukherjee
Zitieren
APA
Pradhan, R., Roy Biswas, R., Mondal, S., & Mukherjee, U. (2025). Immunohistochemical Diversity of Endometrial Carcinoma and Their Implications in Prognosis: A Prospective Clinicopathological Study in a Tertiary Care Hospital of Eastern India. The Journal of Obstetrics and Gynecology of India, 75(S1), 166-172. https://doi.org/10.1007/s13224-024-02046-9
Vancouver
Pradhan R, Roy Biswas R, Mondal S, Mukherjee U. Immunohistochemical Diversity of Endometrial Carcinoma and Their Implications in Prognosis: A Prospective Clinicopathological Study in a Tertiary Care Hospital of Eastern India. The Journal of Obstetrics and Gynecology of India. 2025;75(S1):166-172. doi:10.1007/s13224-024-02046-9
BibTeX
@article{Pradhan2025,
author = {Pradhan, Rajashree and Roy Biswas, Ranu and Mondal, Sajeeb and Mukherjee, Upasana},
title = {Immunohistochemical Diversity of Endometrial Carcinoma and Their Implications in Prognosis: A Prospective Clinicopathological Study in a Tertiary Care Hospital of Eastern India},
journal = {The Journal of Obstetrics and Gynecology of India},
year = {2025},
volume = {75},
number = {S1},
pages = {166--172},
doi = {10.1007/s13224-024-02046-9}
}
EUVIMED